EUR 118.6
(-0.08%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 357.6 Million EUR | -20.95% |
2022 | 452.4 Million EUR | -24.74% |
2021 | 601.1 Million EUR | 48.64% |
2020 | 404.4 Million EUR | 48.24% |
2019 | 272.8 Million EUR | 6.31% |
2018 | 256.6 Million EUR | 7.77% |
2017 | 238.1 Million EUR | 32.94% |
2016 | 179.1 Million EUR | 62.08% |
2015 | 110.5 Million EUR | -18.09% |
2014 | 134.9 Million EUR | -17.89% |
2013 | 164.3 Million EUR | 22.25% |
2012 | 134.4 Million EUR | -16.26% |
2011 | 160.5 Million EUR | 0.31% |
2010 | 160 Million EUR | 7.96% |
2009 | 148.2 Million EUR | 14.0% |
2008 | 130 Million EUR | 32.52% |
2007 | 98.1 Million EUR | -6.84% |
2006 | 105.3 Million EUR | 16.87% |
2005 | 90.1 Million EUR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 215.3 Million EUR | 0.0% |
2023 Q2 | 161.6 Million EUR | 0.0% |
2023 FY | 357.6 Million EUR | -20.95% |
2023 Q4 | 196 Million EUR | 0.0% |
2022 Q4 | 224.3 Million EUR | 0.0% |
2022 Q2 | 228 Million EUR | 0.0% |
2022 FY | 452.4 Million EUR | -24.74% |
2021 FY | 601.1 Million EUR | 48.64% |
2021 Q4 | 324 Million EUR | 0.0% |
2021 Q2 | 277.1 Million EUR | 0.0% |
2020 Q2 | 172.9 Million EUR | 0.0% |
2020 Q4 | 231.5 Million EUR | 0.0% |
2020 FY | 404.4 Million EUR | 48.24% |
2019 Q2 | 140.5 Million EUR | 0.0% |
2019 FY | 272.8 Million EUR | 6.31% |
2019 Q4 | 132.3 Million EUR | 0.0% |
2018 Q2 | 134.19 Million EUR | 0.0% |
2018 FY | 256.6 Million EUR | 7.77% |
2018 Q4 | 122.3 Million EUR | 0.0% |
2017 Q2 | 101.1 Million EUR | 0.0% |
2017 FY | 238.1 Million EUR | 32.94% |
2017 Q4 | 137 Million EUR | 0.0% |
2016 Q4 | 93.4 Million EUR | 0.0% |
2016 Q2 | 85.7 Million EUR | 0.0% |
2016 FY | 179.1 Million EUR | 62.08% |
2015 FY | 110.5 Million EUR | -18.09% |
2015 Q4 | 50.9 Million EUR | 0.0% |
2015 Q2 | 59.6 Million EUR | 0.0% |
2014 Q2 | 50.4 Million EUR | 0.0% |
2014 FY | 134.9 Million EUR | -17.89% |
2014 Q4 | 84.5 Million EUR | 0.0% |
2013 Q4 | 84.6 Million EUR | 0.0% |
2013 Q2 | 79.7 Million EUR | 0.0% |
2013 FY | 164.3 Million EUR | 22.25% |
2012 Q1 | 33.57 Million EUR | 0.0% |
2012 Q3 | 33.57 Million EUR | 0.0% |
2012 Q2 | - EUR | -100.0% |
2012 Q4 | - EUR | -100.0% |
2012 FY | 134.4 Million EUR | -16.26% |
2011 Q1 | 40.12 Million EUR | 0.0% |
2011 Q4 | - EUR | -100.0% |
2011 FY | 160.5 Million EUR | 0.31% |
2011 Q3 | 40.12 Million EUR | 0.0% |
2011 Q2 | - EUR | -100.0% |
2010 Q1 | 40 Million EUR | 0.0% |
2010 Q3 | 40 Million EUR | 0.0% |
2010 FY | 160 Million EUR | 7.96% |
2010 Q4 | - EUR | -100.0% |
2010 Q2 | - EUR | -100.0% |
2009 FY | 148.2 Million EUR | 14.0% |
2009 Q3 | 37.05 Million EUR | 0.0% |
2009 Q4 | - EUR | -100.0% |
2009 Q1 | 37.05 Million EUR | 12.87% |
2009 Q2 | 37.05 Million EUR | 0.0% |
2008 Q1 | 32.82 Million EUR | 31.96% |
2008 Q4 | 32.82 Million EUR | 0.0% |
2008 Q3 | 32.82 Million EUR | 0.0% |
2008 Q2 | 32.82 Million EUR | 0.0% |
2008 FY | 130 Million EUR | 32.52% |
2007 Q1 | 24.87 Million EUR | -5.6% |
2007 Q4 | 24.87 Million EUR | 0.0% |
2007 Q3 | 24.87 Million EUR | 0.0% |
2007 Q2 | 24.87 Million EUR | 0.0% |
2007 FY | 98.1 Million EUR | -6.84% |
2006 Q4 | 26.35 Million EUR | 0.0% |
2006 FY | 105.3 Million EUR | 16.87% |
2006 Q1 | 26.35 Million EUR | 16.98% |
2006 Q2 | 26.35 Million EUR | 0.0% |
2006 Q3 | 26.35 Million EUR | 0.0% |
2005 FY | 90.1 Million EUR | 0.0% |
2005 Q3 | 22.52 Million EUR | 0.0% |
2005 Q2 | 22.52 Million EUR | 0.0% |
2005 Q4 | 22.52 Million EUR | 0.0% |
2005 Q1 | 22.52 Million EUR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Biosynex SA | -36.94 Million EUR | 1067.899% |
Predilife S.A. | -4.22 Million EUR | 8565.693% |
Eurofins Scientific SE | 310.2 Million EUR | -15.28% |
Lumibird SA | 7.12 Million EUR | -4918.243% |